Pharmaceutical - Asia-Pacific

Filter

Current filters:

Asia-Pacific

Popular Filters

126 to 150 of 647 results

GNI Group out-licenses Etuary to AFT Pharma

10-12-2013

Japan headquartered GNI Group, a clinical-stage bio-pharmaceutical company focusing on major diseases…

Asia-PacificLicensingPharmaceuticalRespiratory and Pulmonary

New Zealand funding plans for Tarceva and Revolade

New Zealand funding plans for Tarceva and Revolade

09-12-2013

Following a consultation, New Zealand’s Pharmaceutical Management Agency PHARMAC said this morning…

Asia-PacificGlaxoSmithKlineHematologyNew ZealandOncologyPharmaceuticalPricingRegulationRevoladeRocheTarceva

Medicine prescribing in New Zealand hits new high as PHARMAC role expands

07-12-2013

New Zealanders have gained greater access to medicines in 2013, and record numbers of New Zealanders…

Asia-PacificHealthcareNew ZealandPharmaceuticalRegulation

Should patients appreciate pharma?

Should patients appreciate pharma?

06-12-2013

Here's our take on the week's top stories.

Asia-PacificBayerEuropeFinancialHealthcareManagementPharmaceutical

Review of key drivers of migraine market growth through 2022

06-12-2013

Use of Allergan’s Botox (botulinum toxin type A) for the prophylactic treatment of chronic migraine…

AllerganAsia-PacificBotoxCoLucid PharmaceuticalsEuropelasmiditanLevadexMarkets & MarketingNeurologicalNorth AmericaPharmaceutical

Report 5: Growth strategies in Japan’s pharma market - Research & Development – by P Reed Maurer

Report 5: Growth strategies in Japan’s pharma market - Research & Development – by P Reed Maurer

06-12-2013

From the end of World War II until 1973, pharmaceutical patents in Japan were granted for processes rather…

Asia-PacificPatentsPharmaceuticalResearch

Takeda to commercialize Teva’s glatiramer acetate for MS in Japan

Takeda to commercialize Teva’s glatiramer acetate for MS in Japan

05-12-2013

Revealing an earlier agreement yesterday, Israel’s Teva Pharmaceutical Industries and Japan’s largest…

Asia-PacificCopaxoneGlatiramer AcetateLicensingNeurologicalPharmaceuticalRegulationTakeda PharmaceuticalsTeva Pharmaceutical Industries

Report 4: Growth strategies in Japan’s pharma market – Products – by P Reed Maurer

Report 4: Growth strategies in Japan’s pharma market – Products – by P Reed Maurer

05-12-2013

Japan has a long history of rewarding innovation across many industrial sectors, including the pharmaceutical…

Asia-PacificMarkets & MarketingPharmaceuticalPricing

Report 3: Growth strategies in Japan’s pharma market – People - P Reed Maurer

Report 3: Growth strategies in Japan’s pharma market – People - P Reed Maurer

04-12-2013

It is the people that set the Pharma industry apart from other industries. In one company you have an…

Asia-PacificManagementPharmaceutical

MRCF invests in Australian antibiotics start-up Auspherix

03-12-2013

Auspherix Pty, an early stage anti-infectives company developing novel antibiotics to treat resistant…

Antibiotics and Infectious diseasesAsia-PacificAuspherixAustraliaFinancialPharmaceuticalResearch

Report 2: Growth strategies in Japan’s pharma market - Co-promotion and Co-marketing – by P Reed Maurer

Report 2: Growth strategies in Japan’s pharma market - Co-promotion and Co-marketing – by P Reed Maurer

03-12-2013

In many respects, Japan is the ideal market for pharma companies with new, innovative drugs, according…

Asia-PacificMarkets & MarketingPharmaceutical

New Zealand views access to sugammadex and atomoxetine and baclofen injection funding

02-12-2013

New Zealand’s Pharmaceutical Management Agency PHARMAC is seeking feedback on the following proposals…

Asia-PacificBridionEli LillyLioresal IntrathecalMerck & CoNeurologicalNew ZealandPharmaceuticalRegulationStrattera

Medicines Australia calls on government to review PBS assessment process

Medicines Australia calls on government to review PBS assessment process

02-12-2013

Trade body Medicines Australia has submitted a report to the National Commission of Audit which shows…

Asia-PacificAustraliaHealthcarePharmaceuticalPoliticsPricing

Report 1: Growth strategies in Japan’s pharma market, by P Reed Maurer

Report 1: Growth strategies in Japan’s pharma market, by P Reed Maurer

02-12-2013

P Reed Maurer, long-time Japanese pharma industry watcher and president of International Alliances Limited,…

Asia-PacificMergers & AcquisitionsPharmaceutical

Eisai’s R&D organization undergoes “transformation”

Eisai’s R&D organization undergoes “transformation”

30-11-2013

Japanese drugmaker Eisai's president and chief executive, Haruo Naito, says that the company's R&D organization,…

Asia-PacificEisaiEuropeManagementNorth AmericaPharmaceuticalResearchUSA

Daiichi Sankyo launches Biopten Granules 10% in Japan

Daiichi Sankyo launches Biopten Granules 10% in Japan

29-11-2013

Japanese drug major Daiichi Sankyo has launched natural tetrahydrobiopterin agent Biopten Granules 10%…

Asia-PacificBioptenDaiichi SankyoMarkets & MarketingPharmaceuticalRare diseases

Bayer files VEGF Trap-Eye for myopic choroidal neovascularization in Japan

Bayer files VEGF Trap-Eye for myopic choroidal neovascularization in Japan

29-11-2013

German drug major Bayer (BAYN: DE) has submitted VEGF Trap-Eye, already marketed under the brand name…

Asia-PacificBayerEyleaOphthalmicsPharmaceuticalRegeneronRegulationUSA

Different Rxing patterns for premium-priced therapies in China and South Korea

26-11-2013

In China, a combination of government restrictions on reimbursement and regional variations in formulary…

Asia-PacificMarkets & MarketingOncologyPharmaceuticalPricing

Eisai takes over marketing authorization for Gliadel, and joins TB partnership

Eisai takes over marketing authorization for Gliadel, and joins TB partnership

25-11-2013

Japanese drug major Eisai (TYO: 4523) will become the Marketing Authorization Holder for the antineoplastic…

Antibiotics and Infectious diseasesAsia-PacificEisaiGliadelLicensingNobelpharmaOncologyPharmaceutical

Drug approvals for Bayer in USA and Japan

Drug approvals for Bayer in USA and Japan

23-11-2013

There were two pieces of good news for German Pharma and chemicals major Bayer on Friday (November 22),…

AmgenAsia-PacificBayerBiotechnologyEyleaNexavarNorth AmericaOncologyOnyx PharmaceuticalsOphthalmicsPharmaceuticalRegeneronRegulation

India and China to lead modest growth in Asia-Pacific ophthalmology drug market

India and China to lead modest growth in Asia-Pacific ophthalmology drug market

22-11-2013

The ophthalmology therapeutics market for dry eye syndromeand glaucoma in four Asia-Pacificcountries…

Asia-PacificMarkets & MarketingOphthalmicsPharmaceuticalResearch

Cadila Pharma to debut novel lung cancer drug Mycidac-C in India

21-11-2013

Cadila Pharmaceuticals, one of India’s largest privately-held pharmaceuticals company, has launched…

Asia-PacificCadila PharmaceuticalsMarkets & MarketingMycidac-COncologyPharmaceutical

Australia’s TGA streamlines adverse event reporting

21-11-2013

Australia’s medicines regulator the Therapeutic Goods Administration (TGA) has introduced a streamlined…

Asia-PacificPharmaceuticalRegulationResearch

126 to 150 of 647 results

Back to top